Skip to main content
. 2015 Sep 9;23(5):771–779. doi: 10.1007/s12282-015-0637-4

Table 2.

Best objective response at week 24

Goserelin 10.8 mg (n = 88)a Goserelin 3.6 mg (n = 93)a
Complete response, n (%) 1 (1.1) 0
Partial response, n (%) 20 (22.7) 25 (26.9)
ORR, n (%) 21 (23.9) 25 (26.9)
Treatment difference, % (95 % CI) −3.0 (−15.5, 9.7)

CI confidence interval, ORR objective response rate

aIncluded only patients who had measurable disease at baseline